Why do patients with atopic dermatitis refuse to apply topical corticosteroids?

被引:43
|
作者
Fukaya, M [1 ]
机构
[1] Natl Nagoya Hosp, Dept Dermatol, Naka Ku, Nagoya, Aichi, Japan
关键词
topical corticosteroids; atopic dermatitis;
D O I
10.1159/000018495
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: The number of patients with atopic dermatitis who refuse to use topical corticosteroids because of personal fears seems to be increasing. However, studies on this subject are scarce. Consequently, we have investigated this issue further. Methods: A cross-sectional study based on a questionnaire. Between September 1998 and January 1999, a questionnaire was distributed to patients who responded to an announcement and to those attending 18 hospitals or clinics and 11 self-help groups throughout Japan to identify what makes patients resistant to applying topical corticosteroids. Results: Patients who are reluctant to use topical corticosteroids often experienced: ineffective or short-lasting results, adverse side effects and feelings of distrust towards their physician. These feelings of distrust were found to be significantly stronger among patients who were reluctant to apply topical corticosteroids than among patients who accepted the treatment with little or no feelings of resistance. External influences such as those from family members, acquaintances, mass media (television, newspapers and magazines), alternative 'nondoctor' therapists and self-help groups were not found to be a significant Factor between both groups. However, the influence of the physician was found to be significant and directly related to the patients' lack of trust. Conclusions: Patients with atopic dermatitis who refuse to use topical corticosteroids attribute their feelings of resistance to personal experiences rather than to information from external sources. Information or warnings about associated side effects from physicians may help to reduce these fears and ultimately benefit the physician-patient relationship. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:242 / 245
页数:4
相关论文
共 50 条
  • [21] Topical Corticosteroids and Topical Calcineurin Inhibitors in the Treatment of Atopic Dermatitis: Focus on Percutaneous Absorption
    Pariser, David
    AMERICAN JOURNAL OF THERAPEUTICS, 2009, 16 (03) : 264 - 273
  • [22] Detection of contact hypersensitivity to corticosteroids in allergic contact dermatitis patients who do not respond to topical corticosteroids
    Gönül, M
    Gül, Ü
    CONTACT DERMATITIS, 2005, 53 (02) : 67 - 70
  • [23] Assessment of the attitude of dermatologists to the use of topical corticosteroids in paediatric atopic dermatitis
    Smith, S. D.
    Lee, A.
    Blaszczynski, A.
    Fischer, G.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2015, 56 : 69 - 69
  • [24] Topical Use of Corticosteroids among Children and Adolescents with Atopic Dermatitis in Germany
    Du, Yong
    Knopf, Hildtraud
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 132 - 133
  • [25] Corticophobia and adherence to topical corticosteroids in atopic dermatitis treatment in southern Brazil
    Schoenardie, Bruna Ossanai
    Escobar, Gabriela Fortes
    Damke, Jessica Pauli
    Mueller, Gabriel Cardozo
    Bonamigo, Renan Rangel
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2024, 99 (03) : 439 - 442
  • [26] Knowledge of pharmacists in Saudi Arabia on the use of topical corticosteroids in atopic dermatitis
    Alsaiari, Soliman Ayed
    Al Daghreer, Hamad
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (07) : 1093 - 1100
  • [27] Topical corticosteroids for atopic dermatitis [Dermatocorticosteroïden bij constitutioneel eczeem]
    Stewart S.
    Pasmans S.
    De Bruin-Weller M.
    Huisarts en wetenschap, 2013, 56 (7) : 346 - 350
  • [28] The effect of topical corticosteroids on bone mineral density in adults with atopic dermatitis
    Mu, Zhanglei
    Zhang, Jianzhong
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (01) : 181 - 182
  • [29] Knowledge, attitude, and practice of the use of topical corticosteroids in children with atopic dermatitis
    Sendrasoa, Fandresena Arilala
    Rakotoniaina, Jonah Mamitiana
    Ramarozatovo, Lala Soavina
    Rabenja, Fahafahantsoa Rapelanoro
    JAAD INTERNATIONAL, 2025, 18 : 3 - 4
  • [30] Dupilumab with concomitant topical corticosteroids in atopic dermatitis patients who are inadequately controlled with or medically inadvisable for cyclosporine A
    Bieber, T.
    de Bruin-Weller, M.
    Blauvelt, A.
    Thaci, D.
    Gooderham, M.
    Etoh, T.
    Smith, C.
    Chen, Z.
    Gadkari, A.
    Eckert, L.
    Graham, N. M. H.
    Pirozzi, G.
    Shumel, B.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 : 39 - 39